Paramount Biosciences

Paramount Biosciences was a prominent biotechnology investment and development firm founded by Dr. Lindsay Rosenwald. The company operated as a venture incubator, identifying promising drug candidates from academic institutions and forming new companies to advance their development. Paramount provided comprehensive support, including seed funding, management, and clinical trial oversight for its portfolio companies. Its business model led to the creation of numerous successful biotech entities, most notably Cougar Biotechnology, which developed the blockbuster prostate cancer drug Zytiga. While the firm is no longer active in its original form, its hub-and-spoke development strategy heavily influenced the structure of modern biotech investment vehicles like Fortress Biotech.